Losco Luigi, Bolletta Alberto, de Sire Alessandro, Chen Shih-Heng, Sert Gokhan, Aksoyler Dicle, Velazquez-Mujica Jonathan, Invernizzi Marco, Cigna Emanuele, Chen Hung-Chi
Department of Plastic Surgery, China Medical University, Taichung 404, Taiwan.
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
J Clin Med. 2022 Jan 24;11(3):570. doi: 10.3390/jcm11030570.
Bilateral lower extremity lymphedema is a rare and invalidating condition that poses a great challenge to the scientific community, and deeply affects the quality of life (QoL) of affected patients. A combined protocol consisting of lymph node transfer and a reductive method have never been reported for the treatment of this condition, except for small case series with brief follow-up periods.
This retrospective study analyzed data of 29 patients, mean age 51 ± 17.1 years, who had been diagnosed with bilateral lower extremity lymphedema. Gastroepiploic vascularized lymph node transfer was performed in all the patients, and an excisional procedure was associated according to the clinical stage. Clinical history, circumferential limb measurements, complications, episodes of cellulitis, and responses to the Lymphedema Quality of Life Questionnaire were analyzed.
The mean follow-up was 38.4 ± 11.8 months. A significant reduction in the episodes of cellulitis per year was observed ( < 0.001). In our series, BMI and duration of symptoms were significantly related to the development of cellulitis during the postoperative period, = 0.006 and = 0.020, respectively. The LYMQoL questionnaire showed a significant quality of life improvement from 3.4 ± 0.9 to 6.2 ± 0.8 ( < 0.05).
An integrated approach is essential for the treatment of bilateral lower extremity lymphedema: reductive and reconstructive methods are complementary to achieve a successful outcome. Timely treatment and BMI reduction are relevant in order to decrease the number of episodes of cellulitis. An attentive follow-up is necessary to identify recurrence and treat affected patients in time.
双侧下肢淋巴水肿是一种罕见且使人衰弱的病症,给科学界带来了巨大挑战,并严重影响患者的生活质量(QoL)。除了少数随访期较短的小病例系列外,从未有过关于淋巴结转移与缩减方法联合方案治疗该病症的报道。
这项回顾性研究分析了29例被诊断为双侧下肢淋巴水肿患者的数据,患者平均年龄为51±17.1岁。所有患者均接受了带血管蒂的胃网膜淋巴结转移术,并根据临床分期进行了切除手术。分析了临床病史、肢体周径测量值、并发症、蜂窝织炎发作情况以及对淋巴水肿生活质量问卷的回答。
平均随访时间为38.4±11.8个月。观察到每年蜂窝织炎发作次数显著减少(<0.001)。在我们的系列研究中,BMI和症状持续时间与术后蜂窝织炎的发生显著相关,分别为 = 0.006和 = 0.020。淋巴水肿生活质量问卷显示生活质量从3.4±0.9显著提高到6.2±0.8(<0.05)。
综合治疗方法对于双侧下肢淋巴水肿的治疗至关重要:缩减和重建方法相辅相成,以实现成功的治疗效果。为了减少蜂窝织炎发作次数,及时治疗和降低BMI很重要。需要密切随访以识别复发情况并及时治疗受影响的患者。